Follow
Promore Pharma AB
Nasdaq First North Sweden (Sweden)
Promore Pharma AB is a biopharmaceutical company. It provides medical aid for patients with large unmet medical need within the field of bioactive wound care, through the development of products that enhance and accelerate natural healing processes in the body. It has two therapeutic peptides, PXL01 and LL-37, in late-stage clinical development.
Sector:
HEALTH CARE
>
Biotechnology
Sector:
TECHNOLOGY
New issue
Price
3.71 SEK
Subscription period
13 Nov - 28 Nov 2019
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
PROMO
SE0009947740
Nasdaq First North Sweden
Sweden (SE)
Details of share in Promore Pharma AB with ticker PROMO
Status
Active
Order book id
Amount of instruments
20 235 090
Par value
0.0400
Market cap
Currency
SEK
Segment
First North
First trading date
06 Jul 2017
Terms
Type
Price
Pre-money valuation
Time
IPO
23.30 SEK
39.5M SEK
08 Jun - 22 Jun 2017
IPO in Promore Pharma AB
Market
Nasdaq First North Sweden
Subscription period
08 Jun - 22 Jun 2017
Subscription price
23.30 SEK
Price per share
23.30 SEK
Target to raise
106 000 000 SEK
Types
Pre-money valuation
39 500 000 SEK
Subscription block size
Minimum subscription
250
Record date
Offer status
Closed
Listing status
Listed
First trading date
06 Jul 2017
Issue terms
The offer is aimed at the general public in Sweden and Norway and institutional investors.
Type
Price
Pre-money valuation
Time
Exercise
23.30 SEK
-
04 Feb - 22 Feb 2019
Option exercise terms for PROMO TO1
Former ticker
PROMO TO 1
Market
Nasdaq First North Sweden
Exercise period(s)
04 Feb - 22 Feb 2019
Exercise price
23.30 SEK
Status
Closed
Issue terms
Three (3) equity rights give the right to subscribe for one (1) new share in Promore Pharma AB. Strike price shall be 70% of the volume weighted average price per share during the period January 21 – January 31, 2019. However, strike price shall be a minimum of 23.30 SEK per share and a maximum of 46.60 SEK per share
Type
Price
Pre-money valuation
Time
New issue
3.71 SEK
75M SEK
13 Nov - 28 Nov 2019
Share issue in Promore Pharma AB
Market
Nasdaq First North Sweden
Subscription period
13 Nov - 28 Nov 2019
Subscription price
3.71 SEK
Price per share
3.71 SEK
Target to raise
75 000 000 SEK
Types
Share issue
Pre-money valuation
75 000 000 SEK
Subscription block size
Minimum subscription
Record date
06 Oct 2019
Offer status
Active
Listing status
Listed
Issue terms
Preference right 1:1. For each (1) share held per record day (06.10.2019), one (1) subscription right is obtained. One (1) subscription right entitles the holder to subscribe for one (1) new share.
Comments for offer & related information
Amount of offered shares 20 235 090.
Midroc New Technology AB, which holds approximately 33.7 percent of the Company's outstanding shares, and PharmaResearch Products Ltd, which holds approximately 23.6 percent of the Company's outstanding shares, have undertaken to subscribe for approximately SEK 25 million, corresponding to its pro rata share , and SEK 10 million respectively in the Rights Issue. In total, these subscription commitments amount to approximately SEK 35 million, corresponding to 47.0 percent of the Rights Issue.
In addition, Promore Pharma has received issue guarantees from external investors of up to approximately SEK 25 million, corresponding to up to 33.0 percent of the Rights Issue. In total, the Rights Issue is thus guaranteed up to an amount of approximately SEK 60 million, corresponding to approximately 80 percent of the issue amount.
Type
Ticker
ISIN
Market
SHARE
PROMO
SE0009947740
Nasdaq First North Sweden
Sweden (SE)
Details of share in Promore Pharma AB with ticker PROMO
Status
Active
Order book id
Amount of instruments
20 235 090
Par value
0.0400
Market cap
Currency
SEK
Segment
First North
First trading date
06 Jul 2017
Terms
Type
Price
Pre-money valuation
Time
IPO
23.30 SEK
39.5M SEK
08 Jun - 22 Jun 2017
IPO in Promore Pharma AB
Market
Nasdaq First North Sweden
Subscription period
08 Jun - 22 Jun 2017
Subscription price
23.30 SEK
Price per share
23.30 SEK
Target to raise
106 000 000 SEK
Types
Pre-money valuation
39 500 000 SEK
Subscription block size
Minimum subscription
250
Record date
Offer status
Closed
Listing status
Listed
First trading date
06 Jul 2017
Issue terms
The offer is aimed at the general public in Sweden and Norway and institutional investors.
Type
Price
Pre-money valuation
Time
New issue
3.71 SEK
75M SEK
13 Nov - 28 Nov 2019
Share issue in Promore Pharma AB
Market
Nasdaq First North Sweden
Subscription period
13 Nov - 28 Nov 2019
Subscription price
3.71 SEK
Price per share
3.71 SEK
Target to raise
75 000 000 SEK
Types
Share issue
Pre-money valuation
75 000 000 SEK
Subscription block size
Minimum subscription
Record date
06 Oct 2019
Offer status
Active
Listing status
Listed
Issue terms
Preference right 1:1. For each (1) share held per record day (06.10.2019), one (1) subscription right is obtained. One (1) subscription right entitles the holder to subscribe for one (1) new share.
Comments for offer & related information
Amount of offered shares 20 235 090.
Midroc New Technology AB, which holds approximately 33.7 percent of the Company's outstanding shares, and PharmaResearch Products Ltd, which holds approximately 23.6 percent of the Company's outstanding shares, have undertaken to subscribe for approximately SEK 25 million, corresponding to its pro rata share , and SEK 10 million respectively in the Rights Issue. In total, these subscription commitments amount to approximately SEK 35 million, corresponding to 47.0 percent of the Rights Issue.
In addition, Promore Pharma has received issue guarantees from external investors of up to approximately SEK 25 million, corresponding to up to 33.0 percent of the Rights Issue. In total, the Rights Issue is thus guaranteed up to an amount of approximately SEK 60 million, corresponding to approximately 80 percent of the issue amount.
Type
Ticker
ISIN
Market
OPTION
PROMO TO1
SE0009997158
Nasdaq First North Sweden
Sweden (SE)
Details of option in Promore Pharma AB with ticker PROMO TO1
Status
Archived
Order book id
140252
Amount of instruments
6 523 560
Market cap
Currency
SEK
Segment
First North
First trading date
Terms
Three (3) equity rights give the right to subscribe for one (1) new share in Promore Pharma AB. Strike price shall be 70% of the volume weighted average price per share during the period January 21 – January 31, 2019. However, strike price shall be a minimum of 23.30 SEK per share and a maximum of 46.60 SEK per share
Type
Price
Pre-money valuation
Time
Exercise
23.30 SEK
-
04 Feb - 22 Feb 2019
Option exercise terms for PROMO TO1
Former ticker
PROMO TO 1
Market
Nasdaq First North Sweden
Exercise period(s)
04 Feb - 22 Feb 2019
Exercise price
23.30 SEK
Status
Closed
Issue terms
Three (3) equity rights give the right to subscribe for one (1) new share in Promore Pharma AB. Strike price shall be 70% of the volume weighted average price per share during the period January 21 – January 31, 2019. However, strike price shall be a minimum of 23.30 SEK per share and a maximum of 46.60 SEK per share
People
Number of Employees
1 people
Jonas Göran Ekblom
CEO
Mr. Göran Pettersson
Chairman of the board
Mr. Göran Pettersson
Board member
Mrs. Marianne Dicander Alexandersson
Board member
Dr. Torsten Goesch
Board member
Dr. Satyendra Kumar
Board member
Mr. Göran Linder
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY

Address
C/O Pergamum Ab
Zip code
171 65
City/district
Solna
Country
Sweden (SE)
Registration number
556639-6809
LEI code
549300FJYXYRTU6R3M15
First trade date
06 Jul 2017
Registration date
29 Jan 2003
Short name
Promore Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More